HomeSONN • NASDAQ
add
Sonnet BioTherapeutics Holdings, Inc.
Previous close
$2.89
Day range
$2.88 - $3.00
Year range
$2.50 - $18.72
Market cap
2.50M USD
Avg Volume
925.43K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
1 day ago
Nvidia and the Magnificent Seven make up too much of your high-priced index
fund
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.80M | 16.79% |
Net income | -3.51M | 11.18% |
Net profit margin | — | — |
Earnings per share | -5.60 | 75.52% |
EBITDA | -3.53M | 9.88% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.55M | -49.38% |
Total assets | 5.80M | -42.23% |
Total liabilities | 3.18M | -51.96% |
Total equity | 2.62M | — |
Shares outstanding | 682.66K | — |
Price to book | 0.72 | — |
Return on assets | -150.72% | — |
Return on capital | -294.47% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -3.51M | 11.18% |
Cash from operations | -3.07M | 50.27% |
Cash from investing | -12.00K | 0.00% |
Cash from financing | 2.85M | 57.02% |
Net change in cash | -231.85K | 94.69% |
Free cash flow | -1.93M | 58.54% |
About
Founded
1999
Headquarters
Website
Employees
12
